Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Prognostic Tool for Predicting Prognosis in Early Stage Chronic Lymphocytic Leukemia Patients

NCT03436524 is registered in ClinicalTrials.gov with Oncology Institute of Southern Switzerland as lead sponsor.

NCT NCT03436524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03436524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Prognostic Tool for Predicting Prognosis in Early Stage Chronic Lymphocytic Leukemia Patients
Lead sponsor
Oncology Institute of Southern Switzerland
Phase
Observational
Overall status
Completed
Start date
March 1, 2018
Completion date
February 28, 2020
Enrollment
4,933 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia